|
Tavist-1Drug - Tavist-1 The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Clemastine Fumarate
Strength -
1.34MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
017661
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 21, 1992
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Tavist-1
Tavist Eq 0.5mg Base/5ml Syrup; Oral
Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 2.68mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 1.34mg Tablet; Oral Clemastine Fumarate 2.68mg Tablet; Oral Tavist 2.68mg Tablet; Oral Tavist-1 1.34mg Tablet; Oral Tavist-1 1.34mg Tablet; Oral NewDrugInformation |